In recent years, there have been many bad times in which to be long biotechnology stocks and exchange traded funds, but with some marquee industry conferences imminent, the biotech industry is in the midst of one of its most potent seasonal periods.December is the second-best month of the year for the broader biotech sector after July, but due to the […]
About Raynovich Rod
Rod Raynovich is an experienced biotech investor an analyst with a focus in vaccines, tools, IVD’s and biopharmaceuticals. Prior to starting Raygent, he was a former technology transfer officer for UCLA and he has held various executive positions in the biotech and pharmaceutical industry, including senior positions at NASDAQ listed medical device companies. He was a founder and […]
Over the last several years, there has rarely been a bad time to own biotechnology exchange traded funds. That much is confirmed by the presence of multiple biotech ETFs on the annual lists of the top 10 sector funds.In 2014, each of the five major biotech ETFs ranked among the year’s top 10 sector ETFs. That includes the First Trust […]
The bull market is nearing six years old. It turns out that the biotech sector again managed a huge outperforming year in 2014 as well. The gains of the key biotech exchange traded funds (ETFs) were up in the 40% range, with the NYSE Arca Biotech index up over 45% year-to-date. The equal-weight biotech ETF performed better than the key larger […]
View gallery.It’s been a rough couple of days for biotech stocks.To start, Gilead Sciences, Inc. (NASDAQ: GILD) has dropped from a high of almost $110 per share on Friday to a low of $86 on Tuesday.Many other big-name biotechs, such as Amgen, Inc. (NASDAQ: AMGN), Biogen Idec Inc (NASDAQ: BIIB) and Valeant Pharmaceuticals Intl Inc (NYSE: VRX) have fallen with […]
The financial media is playing the “when will oil bottom?” game to help fill the 24-hour news cycle—but that’s not going to make you money.So, today I have a trade that will…Sure, crude just took a breather to plug the leaks. It even jumped a couple of bucks. But when all was said and done yesterday, oil landed right back […]
C3BS enrols 240th patient in CHART-1 European trial of C-Cure for treatment of congestive heart failure | Biotech License
Select CategoryBiotech Articles (22)Biotech FAQ (222)Biotech News (465)Biotech Patents (47)Biotech Videos (37)Pharmaceutical News (124)
Link:
C3BS enrols 240th patient in CHART-1 European …
See which stocks are being affected by Social Media
[…]
Healthcare Stocks Not Immune To Bearish Mood
Crude Hits Lowest Level in Five Years
Biotech stocks joined the market sell-off again with all ETFs hit hard.The most volatile XBI was down 4.27% today and 3.55% over 5 days.Technical support is right about here $175.89, next at $170. During the mid-October swoon the XBI hit near $145. YTD the XBI is still up […]
Stocks and Industries that are expected to grow in the next 5-10 yearsAerospace (ITA)• Air and space travel will be more accessible than ever.• Over the next 10 years the private space industry will surge.• Rising transportation demand will accelerate airplane manufacturing.• Drone technology is a growth industry in both private and military sectors.• Cheaper fuel alternatives will develop, […]
Michael A. RobinsonToday I want to reintroduce you to a biotech stock that Wall Street has been pricing as though it were dead money.This biotech company recently filed a stellar earnings report. But those earnings were slightly off analyst expectations, and the share price dipped – making this is yet another stock that sells off after a slight miss, a […]
